Clinical Trial Update: Evaluation of the Effect of 10% Lidocaine Spray Undergoing Coronary Artery Bypass Graft Operation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of 10% lidocaine spray during coronary artery bypass graft surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Lidocaine topical spray (lidocaine)

Snippet

Sponsor: Abant Izzet Baysal University | Conditions: Cardiovascular Diseases, Lidocaine Causing Adverse Effects in Therapeutic Use | Phase 4 | Status: COMPLETED